Ultragenyx Pharmaceutical (RARE) EBITDA Margin Growth (5y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,705.00 |
| Dec 31, 2025 | 5,031.00 |
| Sep 30, 2025 | -4,509.00 |
| Jun 30, 2025 | 3,738.00 |
| Mar 31, 2025 | 22,945.00 |
| Dec 31, 2024 | 19,108.00 |
| Sep 30, 2024 | 36,287.00 |
| Jun 30, 2024 | 38,661.00 |
| Mar 31, 2024 | 39,404.00 |
| Dec 31, 2023 | 45,973.00 |
| Sep 30, 2023 | 61,412.00 |
| Jun 30, 2023 | 60,515.00 |
| Mar 31, 2023 | 75,035.00 |
| Dec 31, 2022 | 447,023.00 |
| Sep 30, 2022 | 4.20 Mn |
| Dec 31, 2021 | 141.09 Mn |
| Sep 30, 2021 | 5.92 Mn |
| Jun 30, 2021 | 34.14 Mn |